Hikma Pharmaceutical | HIK - Loan Capital

Stock Price
1,397.00
Daily Change
11.00 0.79%
Monthly
11.14%
Yearly
-28.76%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $1.49B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Almirall EUR 324.81M 61.32M Dec/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Autolus Therapeutics Ltd USD 251.94M 7.31M Sep/2025
Bayer EUR 31.83B 877M Dec/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Galapagos EUR 5.19M 574K Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Orion EUR 110.6M 4.7M Mar/2026
Recordati EUR 2.18B 89.51M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025